ID

44027

Beschreibung

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00771433

Link

https://clinicaltrials.gov/show/NCT00771433

Stichworte

Versionen (2)
  1. 19.10.17 19.10.17 -
  2. 20.09.21 20.09.21 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

20. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00771433

Englisch

Eligibility Breast Cancer NCT00771433

1 Formulare  
Criteria
Beschreibung

Criteria

diagnosis of breast cancer
Beschreibung

Breast Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0678222
receiving 1 of the following neoadjuvant or adjuvant chemotherapy regimens:
Beschreibung

Chemotherapy Regimen Neoadjuvant | Chemotherapy, Adjuvant

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0600558
UMLS CUI [2]
C0085533
six courses of epirubicin hydrochloride and docetaxel
Beschreibung

Epirubicin Hydrochloride | Docetaxel

Datentyp

boolean

Alias
UMLS CUI [1]
C0700582
UMLS CUI [2]
C0246415
six courses of fluorouracil, epirubicin hydrochloride, and cyclophosphamide (fec) 100 or 3 courses of fec 100 and 3 courses of docetaxel 100
Beschreibung

Fluorouracil | Epirubicin Hydrochloride | Cyclophosphamide | FEC | docetaxel

Datentyp

boolean

Alias
UMLS CUI [1]
C0016360
UMLS CUI [2]
C0700582
UMLS CUI [3]
C0010583
UMLS CUI [4]
C0060133
UMLS CUI [5]
C0246415
must have received at least 2 chemotherapy regimens prior to study therapy
Beschreibung

Chemotherapy Regimen Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
no malignant hematological disease
Beschreibung

Malignant disease Hematologic Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0442867
UMLS CUI [1,2]
C0205488
UMLS CUI [1,3]
C0332197
hormone receptor status not specified
Beschreibung

Hormone Receptor Status Unspecified

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205370
patient characteristics:
Beschreibung

Client Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
menopausal status not specified
Beschreibung

Menopausal Status Unspecified

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3829127
UMLS CUI [1,2]
C0205370
not pregnant or nursing
Beschreibung

Pregnancy Absent | Breast Feeding Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
fertile patients must use effective contraception
Beschreibung

Fertility Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no contraindications to standard neoadjuvant or adjuvant chemotherapy
Beschreibung

Contraindication Absent Chemotherapy Neoadjuvant | Contraindication Absent Adjuvant Chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0392920
UMLS CUI [1,4]
C0600558
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0085533
no known hypersensitivity to g-csf or any of its components
Beschreibung

Hypersensitivity Absent G-CSF | Hypersensitivity Absent G-CSF Component

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0079459
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0079459
UMLS CUI [2,4]
C1705248
no patients deprived of liberty or under guardianship
Beschreibung

Exclusion Prisoners | Exclusion Patients Guardianship Related

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0033167
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C0030705
UMLS CUI [2,3]
C0870627
UMLS CUI [2,4]
C0439849
no psychological, familial, social, or geographical reasons preventing follow-up
Beschreibung

Condition Absent Preventing Follow-up

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C1292733
UMLS CUI [1,4]
C3274571
prior concurrent therapy:
Beschreibung

Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Beschreibung

ID.17

Datentyp

boolean

no concurrent participation in another experimental drug study
Beschreibung

Study Subject Participation Status | Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT00771433

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Breast Carcinoma
Item
diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
Chemotherapy Regimen Neoadjuvant | Chemotherapy, Adjuvant
Item
receiving 1 of the following neoadjuvant or adjuvant chemotherapy regimens:
boolean
C0392920 (UMLS CUI [1,1])
C0600558 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
Epirubicin Hydrochloride | Docetaxel
Item
six courses of epirubicin hydrochloride and docetaxel
boolean
C0700582 (UMLS CUI [1])
C0246415 (UMLS CUI [2])
Fluorouracil | Epirubicin Hydrochloride | Cyclophosphamide | FEC | docetaxel
Item
six courses of fluorouracil, epirubicin hydrochloride, and cyclophosphamide (fec) 100 or 3 courses of fec 100 and 3 courses of docetaxel 100
boolean
C0016360 (UMLS CUI [1])
C0700582 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0060133 (UMLS CUI [4])
C0246415 (UMLS CUI [5])
Chemotherapy Regimen Quantity
Item
must have received at least 2 chemotherapy regimens prior to study therapy
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Malignant disease Hematologic Absent
Item
no malignant hematological disease
boolean
C0442867 (UMLS CUI [1,1])
C0205488 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Hormone Receptor Status Unspecified
Item
hormone receptor status not specified
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Menopausal Status Unspecified
Item
menopausal status not specified
boolean
C3829127 (UMLS CUI [1,1])
C0205370 (UMLS CUI [1,2])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Contraindication Absent Chemotherapy Neoadjuvant | Contraindication Absent Adjuvant Chemotherapy
Item
no contraindications to standard neoadjuvant or adjuvant chemotherapy
boolean
C1301624 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C0600558 (UMLS CUI [1,4])
C1301624 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0085533 (UMLS CUI [2,3])
Hypersensitivity Absent G-CSF | Hypersensitivity Absent G-CSF Component
Item
no known hypersensitivity to g-csf or any of its components
boolean
C0020517 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0079459 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0079459 (UMLS CUI [2,3])
C1705248 (UMLS CUI [2,4])
Exclusion Prisoners | Exclusion Patients Guardianship Related
Item
no patients deprived of liberty or under guardianship
boolean
C2828389 (UMLS CUI [1,1])
C0033167 (UMLS CUI [1,2])
C2828389 (UMLS CUI [2,1])
C0030705 (UMLS CUI [2,2])
C0870627 (UMLS CUI [2,3])
C0439849 (UMLS CUI [2,4])
Condition Absent Preventing Follow-up
Item
no psychological, familial, social, or geographical reasons preventing follow-up
boolean
C0348080 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C3274571 (UMLS CUI [1,4])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.17
Item
see disease characteristics
boolean
Study Subject Participation Status | Investigational New Drugs
Item
no concurrent participation in another experimental drug study
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video